Name: UMIN ID:
Unique ID issued by UMIN | UMIN000031646 |
---|---|
Receipt number | R000036136 |
Scientific Title | Evaluation of the efficacy and safety of 5mg olanzapine combined with aprepitant, granisetron and dexamethasone to prevent carboplatin-induced nausea and vomiting in gynecologic cancer patients: a multicenter phase 2 study. |
Date of disclosure of the study information | 2018/04/05 |
Last modified on | 2020/01/16 17:00:35 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/03/09 10:02:07 | ||
2 | Update | 2018/03/15 09:46:14 | Key secondary outcomes |
|
3 | Update | 2018/04/05 13:34:53 | Recruitment status Anticipated trial start date |
|
4 | Update | 2018/04/05 13:37:46 | Research ethics review Date of disclosure of the study information |
|
5 | Update | 2019/08/19 09:52:36 | Recruitment status Date of IRB Last follow-up date |
|
6 | Update | 2020/01/16 16:58:07 | Recruitment status |
|
7 | Update | 2020/01/16 16:58:35 | Publication of results Number of participants that the trial has enrolled |
|
8 | Update | 2020/01/16 17:00:35 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |